AstraZeneca's Imfinzi with pre-surgery drug boosts survival in bladder cancer trial
- Posted on May 14, 2026
- By Bing News
- 0 Views
- 1 min read
AstraZeneca's Imfinzi with pre-surgery drug boosts survival in bladder cancer trial
May 14 (Reuters) - AstraZeneca said on Thursday that a late-stage trial of Imfinzi, combined with a targeted therapy prior to a surgery, showed significantly improved survival rate in patients with muscle-invasive bladder cancer. The Anglo-Swedish drugmaker, however, said overall survival from a combination of its two cancer drugs Imfinzi and Imjudo with the pre-surgery drug was not statistically
